Benefits and Safety of Long-Term Fenofibrate Therapy in People With Type 2 Diabetes and Renal Impairment: The FIELD Study

R.D. Ting; A.C. Keech; P.L. Drury; M.W. Donoghoe; J. Hedley; A.J. Jenkins; Timothy Davis; S. Lehto; D. Celermajer; R.J. Simes; K. Rajamani; K. Stanton

doi:10.2337/dc11-1109

Benefits and Safety of Long-Term Fenofibrate Therapy in People With Type 2 Diabetes and Renal Impairment: The FIELD Study

R.D. Ting, A.C. Keech, P.L. Drury, M.W. Donoghoe, J. Hedley, A.J. Jenkins, Timothy Davis, S. Lehto, D. Celermajer, R.J. Simes, K. Rajamani, K. Stanton

Research output: Contribution to journal › Article

75 Citations (Scopus)

Original language	English
Pages (from-to)	218-225
Journal	Diabetes Care
Volume	35
Issue number	2
DOIs	https://doi.org/10.2337/dc11-1109
Publication status	Published - 2012

Access to Document

10.2337/dc11-1109

Cite this

Ting, R. D., Keech, A. C., Drury, P. L., Donoghoe, M. W., Hedley, J., Jenkins, A. J., Davis, T., Lehto, S., Celermajer, D., Simes, R. J., Rajamani, K., & Stanton, K. (2012). Benefits and Safety of Long-Term Fenofibrate Therapy in People With Type 2 Diabetes and Renal Impairment: The FIELD Study. Diabetes Care, 35(2), 218-225. https://doi.org/10.2337/dc11-1109

@article{47a06912b77f4ef3bc68754462b06b28,

title = "Benefits and Safety of Long-Term Fenofibrate Therapy in People With Type 2 Diabetes and Renal Impairment: The FIELD Study",

author = "R.D. Ting and A.C. Keech and P.L. Drury and M.W. Donoghoe and J. Hedley and A.J. Jenkins and Timothy Davis and S. Lehto and D. Celermajer and R.J. Simes and K. Rajamani and K. Stanton",

year = "2012",

doi = "10.2337/dc11-1109",

language = "English",

volume = "35",

pages = "218--225",

journal = "Diabetes Care",

issn = "0149-5992",

publisher = "American Diabetes Association",

number = "2",

}

Benefits and Safety of Long-Term Fenofibrate Therapy in People With Type 2 Diabetes and Renal Impairment: The FIELD Study. / Ting, R.D.; Keech, A.C.; Drury, P.L.; Donoghoe, M.W.; Hedley, J.; Jenkins, A.J.; Davis, Timothy; Lehto, S.; Celermajer, D.; Simes, R.J.; Rajamani, K.; Stanton, K.

In: Diabetes Care, Vol. 35, No. 2, 2012, p. 218-225.

Research output: Contribution to journal › Article

TY - JOUR

T1 - Benefits and Safety of Long-Term Fenofibrate Therapy in People With Type 2 Diabetes and Renal Impairment: The FIELD Study

AU - Ting, R.D.

AU - Keech, A.C.

AU - Drury, P.L.

AU - Donoghoe, M.W.

AU - Hedley, J.

AU - Jenkins, A.J.

AU - Davis, Timothy

AU - Lehto, S.

AU - Celermajer, D.

AU - Simes, R.J.

AU - Rajamani, K.

AU - Stanton, K.

PY - 2012

Y1 - 2012

U2 - 10.2337/dc11-1109

DO - 10.2337/dc11-1109

M3 - Article

C2 - 22210576

VL - 35

SP - 218

EP - 225

JO - Diabetes Care

JF - Diabetes Care

SN - 0149-5992

IS - 2

ER -